vs
Federal Realty Investment Trust（FRT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Federal Realty Investment Trust的季度营收约是REPLIGEN CORP的1.7倍（$336.0M vs $197.9M），Federal Realty Investment Trust净利率更高（38.6% vs 6.7%，领先31.9%），REPLIGEN CORP同比增速更快（13.6% vs 8.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.5%）
Federal Realty Investment Trust是一家专业房地产投资信托基金，核心投资标的为购物中心类商业物业，资产布局覆盖美国东北部、大西洋中部地区、加利福尼亚州及南佛罗里达区域，在当地商业不动产投资领域拥有丰富的运营经验。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FRT vs RGEN — 直观对比
营收规模更大
FRT
是对方的1.7倍
$197.9M
营收增速更快
RGEN
高出4.9%
8.7%
净利率更高
FRT
高出31.9%
6.7%
两年增速更快
RGEN
近两年复合增速
6.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $336.0M | $197.9M |
| 净利润 | $129.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 53.8% | 9.0% |
| 净利率 | 38.6% | 6.7% |
| 营收同比 | 8.7% | 13.6% |
| 净利润同比 | 103.5% | 143.9% |
| 每股收益（稀释后） | $1.49 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRTRGEN
| Q1 26 | $336.0M | — | ||
| Q4 25 | $336.0M | $197.9M | ||
| Q3 25 | $322.3M | $188.8M | ||
| Q2 25 | $311.5M | $182.4M | ||
| Q1 25 | $309.2M | $169.2M | ||
| Q4 24 | $311.4M | $174.1M | ||
| Q3 24 | $303.6M | $154.9M | ||
| Q2 24 | $296.1M | $154.1M |
净利润FRTRGEN
| Q1 26 | $129.7M | — | ||
| Q4 25 | $129.7M | $13.3M | ||
| Q3 25 | $61.6M | $14.9M | ||
| Q2 25 | $155.9M | $14.9M | ||
| Q1 25 | $63.8M | $5.8M | ||
| Q4 24 | $65.5M | $-30.3M | ||
| Q3 24 | $61.0M | $-654.0K | ||
| Q2 24 | $112.0M | $3.3M |
毛利率FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率FRTRGEN
| Q1 26 | 53.8% | — | ||
| Q4 25 | 53.8% | 9.0% | ||
| Q3 25 | 34.3% | 8.9% | ||
| Q2 25 | 65.1% | 7.6% | ||
| Q1 25 | 35.0% | 3.9% | ||
| Q4 24 | 35.1% | -17.7% | ||
| Q3 24 | 34.9% | -5.1% | ||
| Q2 24 | 53.0% | 1.0% |
净利率FRTRGEN
| Q1 26 | 38.6% | — | ||
| Q4 25 | 38.6% | 6.7% | ||
| Q3 25 | 19.1% | 7.9% | ||
| Q2 25 | 50.0% | 8.2% | ||
| Q1 25 | 20.6% | 3.4% | ||
| Q4 24 | 21.0% | -17.4% | ||
| Q3 24 | 20.1% | -0.4% | ||
| Q2 24 | 37.8% | 2.2% |
每股收益（稀释后）FRTRGEN
| Q1 26 | $1.49 | — | ||
| Q4 25 | $1.49 | $0.24 | ||
| Q3 25 | $0.69 | $0.26 | ||
| Q2 25 | $1.78 | $0.26 | ||
| Q1 25 | $0.72 | $0.10 | ||
| Q4 24 | $0.74 | $-0.55 | ||
| Q3 24 | $0.70 | $-0.01 | ||
| Q2 24 | $1.32 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $107.4M | $767.6M |
| 总债务越低越好 | $5.0B | $542.2M |
| 股东权益账面价值 | $3.2B | $2.1B |
| 总资产 | $9.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.53× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FRTRGEN
| Q1 26 | $107.4M | — | ||
| Q4 25 | $107.4M | $767.6M | ||
| Q3 25 | $111.3M | $748.7M | ||
| Q2 25 | $177.0M | $708.9M | ||
| Q1 25 | $109.2M | $697.2M | ||
| Q4 24 | $123.4M | $757.4M | ||
| Q3 24 | $97.0M | $784.0M | ||
| Q2 24 | $103.2M | $809.1M |
总债务FRTRGEN
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.5B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FRTRGEN
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $2.1B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.2B | $2.1B | ||
| Q1 25 | $3.2B | $2.0B | ||
| Q4 24 | $3.2B | $2.0B | ||
| Q3 24 | $3.1B | $2.0B | ||
| Q2 24 | $3.0B | $2.0B |
总资产FRTRGEN
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | $2.9B | ||
| Q3 25 | $8.9B | $2.9B | ||
| Q2 25 | $8.6B | $2.9B | ||
| Q1 25 | $8.6B | $2.9B | ||
| Q4 24 | $8.5B | $2.8B | ||
| Q3 24 | $8.5B | $2.8B | ||
| Q2 24 | $8.4B | $2.9B |
负债/权益比FRTRGEN
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.53× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.42× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | $622.4M | $25.7M | ||
| Q3 25 | $147.8M | $48.1M | ||
| Q2 25 | $150.7M | $28.6M | ||
| Q1 25 | $179.0M | $15.0M | ||
| Q4 24 | $574.6M | $39.2M | ||
| Q3 24 | $144.1M | $49.3M | ||
| Q2 24 | $169.7M | $42.2M |
自由现金流FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率FRTRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.80× | 1.93× | ||
| Q3 25 | 2.40× | 3.23× | ||
| Q2 25 | 0.97× | 1.92× | ||
| Q1 25 | 2.81× | 2.57× | ||
| Q4 24 | 8.77× | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 1.52× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
